Bacteremia Outbreak Due to <i>Achromobacter xylosoxidans</i> in Hospitalized COVID-19 Patients

Background: Hospitalized COVID-19 patients are particularly vulnerable to secondary bacterial infections, which can significantly worsen clinical outcomes. The aim of the study was to identify the cause of bacteremia in a group of hospitalized COVID-19 patients and find out the source of the outbrea...

Full description

Saved in:
Bibliographic Details
Main Authors: Magdalini Tsekoura, Georgios Petridis, Konstantinos Koutsouflianiotis, Styliani Pappa, Anna Papa, Konstantina Kontopoulou
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Microbiology Research
Subjects:
Online Access:https://www.mdpi.com/2036-7481/16/7/156
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850072479232425984
author Magdalini Tsekoura
Georgios Petridis
Konstantinos Koutsouflianiotis
Styliani Pappa
Anna Papa
Konstantina Kontopoulou
author_facet Magdalini Tsekoura
Georgios Petridis
Konstantinos Koutsouflianiotis
Styliani Pappa
Anna Papa
Konstantina Kontopoulou
author_sort Magdalini Tsekoura
collection DOAJ
description Background: Hospitalized COVID-19 patients are particularly vulnerable to secondary bacterial infections, which can significantly worsen clinical outcomes. The aim of the study was to identify the cause of bacteremia in a group of hospitalized COVID-19 patients and find out the source of the outbreak to prevent further spread. Methods: Pathogen identification in blood cultures and sensitivity testing were carried out using the automated VITEK2 system. A total of 110 samples were tested; these were collected from patients’ colonization sites and from surfaces, materials and fluids used in the setting. Furthermore, multilocus sequence typing (MLST) and next-generation sequencing (NGS) were employed to characterize the isolates. Results: <i>Achromobacter xylosoxidans</i> was detected in the blood of nine hospitalized patients and in cotton used for disinfection; all isolates presented an identical antibiotic resistance pattern, and all carried the <i>bla</i><sub>OXA-114</sub> gene which is intrinsic to this species. Infection control measures were implemented promptly. With one exception, all patients recovered and were discharged in good health. Conclusions: This outbreak underscores the urgent need for investigation and control of hospital infections, as bacteremia is associated with increased morbidity, mortality, hospitalization time, and cost. It also highlights the importance of close collaboration among healthcare professionals.
format Article
id doaj-art-05caafdb56174b46b4ad960543d047ec
institution DOAJ
issn 2036-7481
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Microbiology Research
spelling doaj-art-05caafdb56174b46b4ad960543d047ec2025-08-20T02:47:04ZengMDPI AGMicrobiology Research2036-74812025-07-0116715610.3390/microbiolres16070156Bacteremia Outbreak Due to <i>Achromobacter xylosoxidans</i> in Hospitalized COVID-19 PatientsMagdalini Tsekoura0Georgios Petridis1Konstantinos Koutsouflianiotis2Styliani Pappa3Anna Papa4Konstantina Kontopoulou5Laboratory of Clinical Microbiology, G. Gennimatas Tertiary Academic Hospital of Thessaloniki, 54635 Thessaloniki, GreeceInternal Medicine Clinic, G. Gennimatas Tertiary Academic Hospital of Thessaloniki, 54635 Thessaloniki, GreeceInternal Medicine Clinic, G. Gennimatas Tertiary Academic Hospital of Thessaloniki, 54635 Thessaloniki, GreeceDepartment of Microbiology, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceDepartment of Microbiology, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceLaboratory of Clinical Microbiology, G. Gennimatas Tertiary Academic Hospital of Thessaloniki, 54635 Thessaloniki, GreeceBackground: Hospitalized COVID-19 patients are particularly vulnerable to secondary bacterial infections, which can significantly worsen clinical outcomes. The aim of the study was to identify the cause of bacteremia in a group of hospitalized COVID-19 patients and find out the source of the outbreak to prevent further spread. Methods: Pathogen identification in blood cultures and sensitivity testing were carried out using the automated VITEK2 system. A total of 110 samples were tested; these were collected from patients’ colonization sites and from surfaces, materials and fluids used in the setting. Furthermore, multilocus sequence typing (MLST) and next-generation sequencing (NGS) were employed to characterize the isolates. Results: <i>Achromobacter xylosoxidans</i> was detected in the blood of nine hospitalized patients and in cotton used for disinfection; all isolates presented an identical antibiotic resistance pattern, and all carried the <i>bla</i><sub>OXA-114</sub> gene which is intrinsic to this species. Infection control measures were implemented promptly. With one exception, all patients recovered and were discharged in good health. Conclusions: This outbreak underscores the urgent need for investigation and control of hospital infections, as bacteremia is associated with increased morbidity, mortality, hospitalization time, and cost. It also highlights the importance of close collaboration among healthcare professionals.https://www.mdpi.com/2036-7481/16/7/156<i>Achromobacter xylosoxidans</i>bacteremiaoutbreakCOVID-19hospital acquired infectionsecondary bacterial infection
spellingShingle Magdalini Tsekoura
Georgios Petridis
Konstantinos Koutsouflianiotis
Styliani Pappa
Anna Papa
Konstantina Kontopoulou
Bacteremia Outbreak Due to <i>Achromobacter xylosoxidans</i> in Hospitalized COVID-19 Patients
Microbiology Research
<i>Achromobacter xylosoxidans</i>
bacteremia
outbreak
COVID-19
hospital acquired infection
secondary bacterial infection
title Bacteremia Outbreak Due to <i>Achromobacter xylosoxidans</i> in Hospitalized COVID-19 Patients
title_full Bacteremia Outbreak Due to <i>Achromobacter xylosoxidans</i> in Hospitalized COVID-19 Patients
title_fullStr Bacteremia Outbreak Due to <i>Achromobacter xylosoxidans</i> in Hospitalized COVID-19 Patients
title_full_unstemmed Bacteremia Outbreak Due to <i>Achromobacter xylosoxidans</i> in Hospitalized COVID-19 Patients
title_short Bacteremia Outbreak Due to <i>Achromobacter xylosoxidans</i> in Hospitalized COVID-19 Patients
title_sort bacteremia outbreak due to i achromobacter xylosoxidans i in hospitalized covid 19 patients
topic <i>Achromobacter xylosoxidans</i>
bacteremia
outbreak
COVID-19
hospital acquired infection
secondary bacterial infection
url https://www.mdpi.com/2036-7481/16/7/156
work_keys_str_mv AT magdalinitsekoura bacteremiaoutbreakduetoiachromobacterxylosoxidansiinhospitalizedcovid19patients
AT georgiospetridis bacteremiaoutbreakduetoiachromobacterxylosoxidansiinhospitalizedcovid19patients
AT konstantinoskoutsouflianiotis bacteremiaoutbreakduetoiachromobacterxylosoxidansiinhospitalizedcovid19patients
AT stylianipappa bacteremiaoutbreakduetoiachromobacterxylosoxidansiinhospitalizedcovid19patients
AT annapapa bacteremiaoutbreakduetoiachromobacterxylosoxidansiinhospitalizedcovid19patients
AT konstantinakontopoulou bacteremiaoutbreakduetoiachromobacterxylosoxidansiinhospitalizedcovid19patients